Drug price history · CMS NADAC read 11 November 2026
Generic
$0.023 per unit at the 2013 year-end survey (18 NDCs) and $0.027 at the 2026 survey (11 NDCs): +19%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.023 | 18 | |
| 2014 (2014-12-31) | $0.022 | 18 | |
| 2015 (2015-12-30) | $0.023 | 18 | |
| 2016 (2016-12-28) | $0.023 | 20 | |
| 2017 (2017-12-27) | $0.022 | 13 | |
| 2018 (2018-12-26) | $0.022 | 10 | |
| 2019 (2019-12-25) | $0.033 | 10 | |
| 2020 (2020-12-30) | $0.030 | 12 | |
| 2021 (2021-12-29) | $0.024 | 10 | |
| 2022 (2022-12-28) | $0.029 | 10 | |
| 2023 (2023-12-27) | $0.031 | 9 | |
| 2024 (2024-12-25) | $0.027 | 11 | |
| 2025 (2025-12-31) | $0.029 | 11 | |
| 2026 (2026-11-11) | $0.027 | 11 |
Generic
$0.023 per unit at the 2013 year-end survey (13 NDCs) and $0.021 at the 2026 survey (9 NDCs): −8%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.023 | 13 | |
| 2014 (2014-12-31) | $0.022 | 13 | |
| 2015 (2015-12-30) | $0.023 | 13 | |
| 2016 (2016-12-28) | $0.023 | 16 | |
| 2017 (2017-12-27) | $0.022 | 10 | |
| 2018 (2018-12-26) | $0.021 | 9 | |
| 2019 (2019-12-25) | $0.022 | 8 | |
| 2020 (2020-12-30) | $0.023 | 9 | |
| 2021 (2021-12-29) | $0.022 | 8 | |
| 2022 (2022-12-28) | $0.023 | 8 | |
| 2023 (2023-12-27) | $0.024 | 8 | |
| 2024 (2024-12-25) | $0.021 | 9 | |
| 2025 (2025-12-31) | $0.023 | 9 | |
| 2026 (2026-11-11) | $0.021 | 9 |
Generic
$0.021 per unit at the 2013 year-end survey (20 NDCs) and $0.026 at the 2026 survey (11 NDCs): +22%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.021 | 20 | |
| 2014 (2014-12-31) | $0.021 | 20 | |
| 2015 (2015-12-30) | $0.021 | 19 | |
| 2016 (2016-12-28) | $0.021 | 22 | |
| 2017 (2017-12-27) | $0.019 | 15 | |
| 2018 (2018-12-26) | $0.021 | 12 | |
| 2019 (2019-12-25) | $0.025 | 12 | |
| 2020 (2020-12-30) | $0.023 | 15 | |
| 2021 (2021-12-29) | $0.024 | 10 | |
| 2022 (2022-12-28) | $0.028 | 9 | |
| 2023 (2023-12-27) | $0.031 | 9 | |
| 2024 (2024-12-25) | $0.025 | 11 | |
| 2025 (2025-12-31) | $0.031 | 11 | |
| 2026 (2026-11-11) | $0.026 | 11 |
Generic
$0.091 per mL at the 2013 year-end survey (1 NDC) and $0.106 at the 2026 survey (1 NDC): +17%, a thin comparison.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.091 | 1 | |
| 2014 (2014-12-31) | $0.105 | 1 | |
| 2015 (2015-12-30) | $0.106 | 1 | |
| 2016 (2016-12-28) | $0.119 | 1 | |
| 2017 (2017-12-27) | $0.113 | 1 | |
| 2018 (2018-12-26) | $0.115 | 1 | |
| 2020 (2020-12-30) | $0.113 | 1 | |
| 2021 (2021-12-29) | $0.100 | 1 | |
| 2023 (2023-12-27) | $0.103 | 1 | |
| 2024 (2024-12-25) | $0.099 | 1 | |
| 2025 (2025-12-31) | $0.108 | 1 | |
| 2026 (2026-11-11) | $0.106 | 1 |
Generic
$0.834 per mL at the 2013 year-end survey (1 NDC) and $1.08 at the 2026 survey (1 NDC): +30%, a thin comparison.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.834 | 1 | |
| 2014 (2014-12-31) | $0.901 | 1 | |
| 2015 (2015-12-30) | $0.960 | 2 | |
| 2016 (2016-12-28) | $0.968 | 2 | |
| 2017 (2017-12-27) | $0.898 | 2 | |
| 2018 (2018-12-26) | $0.967 | 2 | |
| 2019 (2019-12-25) | $0.806 | 2 | |
| 2020 (2020-12-30) | $0.849 | 2 | |
| 2021 (2021-12-29) | $0.790 | 2 | |
| 2024 (2024-12-25) | $0.966 | 1 | |
| 2025 (2025-12-31) | $0.984 | 1 | |
| 2026 (2026-11-11) | $1.08 | 1 |
Generic
$263 per unit at the 2014 year-end survey (1 NDC) and $267 at the 2023 survey (1 NDC): +1%, a thin comparison.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2014 (2014-12-31) | $263 | 1 | |
| 2015 (2015-12-30) | $249 | 1 | |
| 2016 (2016-12-28) | $261 | 1 | |
| 2017 (2017-12-27) | $258 | 2 | |
| 2018 (2018-12-26) | $257 | 2 | |
| 2019 (2019-12-25) | $255 | 2 | |
| 2020 (2020-12-30) | $250 | 1 | |
| 2021 (2021-12-29) | $243 | 1 | |
| 2022 (2022-12-28) | $252 | 1 | |
| 2023 (2023-12-27) | $267 | 1 |
Generic
$258 per unit at the 2014 year-end survey (1 NDC) and $265 at the 2023 survey (1 NDC): +3%, a thin comparison.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2014 (2014-12-31) | $258 | 1 | |
| 2015 (2015-12-30) | $265 | 1 | |
| 2016 (2016-12-28) | $269 | 1 | |
| 2017 (2017-12-27) | $274 | 2 | |
| 2018 (2018-12-26) | $265 | 2 | |
| 2019 (2019-12-25) | $256 | 2 | |
| 2020 (2020-12-30) | $253 | 1 | |
| 2021 (2021-12-29) | $261 | 1 | |
| 2022 (2022-12-28) | $250 | 1 | |
| 2023 (2023-12-27) | $265 | 1 |
Generic
$218 per unit at the 2014 year-end survey (1 NDC) and $218 at the 2021 survey (1 NDC): +0%, a thin comparison.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2014 (2014-12-31) | $218 | 1 | |
| 2015 (2015-12-30) | $233 | 1 | |
| 2016 (2016-12-28) | $220 | 1 | |
| 2019 (2019-12-25) | $234 | 2 | |
| 2020 (2020-12-30) | $230 | 1 | |
| 2021 (2021-12-29) | $218 | 1 |
Generic
$250 per unit at the 2024 year-end survey (2 NDCs) and $213 at the 2026 survey (2 NDCs): −15%, a thin comparison.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2024 (2024-12-25) | $250 | 2 | |
| 2025 (2025-12-31) | $222 | 1 | |
| 2026 (2026-11-11) | $213 | 2 |
Generic
$250 per unit at the 2024 year-end survey (2 NDCs) and $213 at the 2026 survey (2 NDCs): −15%, a thin comparison.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2024 (2024-12-25) | $250 | 2 | |
| 2025 (2025-12-31) | $222 | 2 | |
| 2026 (2026-11-11) | $213 | 2 |
10 more products are on the full page.
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
The FDA Orange Book lists 10 generic makers as marketed in its largest dosage form for Diazepam, and the first generic approval is dated 4 September 1985. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.
Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Diazepam on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).